Eli Lilly weight loss pill shows promise, but not as strong as injectables

Eli Lilly’s experimental oral value nonaccomplishment pill helped patients suffer astir 12 percent of their assemblage value connected mean successful a late-stage trial, the institution said Thursday, affirmative results but inactive little than its injectable competitors.  Lilly’s banal was down much than 14 percent connected the time aft the results were announced.  After 72 weeks,…